Pregnancy Care Products Market Size Worth $33.22 Million By 2025

The global pregnancy care products market size is expected to reach USD 33.22 million by 2025 at a 5.1% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Increasing awareness regarding use of personal care products during pregnancy and high adoption of organic products are driving the market.

A shift in trend toward adoption of organic maternity personal care products owing to safety concerns over chemical-based products is changing the scenario of the overall market. Furthermore, new as well as existing players are introducing organic or herbal variants to increase their market presence and product positioning. In addition, rising awareness and increasing influence of advertising and social media campaigns are boosting the adoption of pregnancy care products.

Doctors do not recommend the use of certain chemicals such as salicylic acid, retinol, toluene, and beta hydroxy acids during pregnancy as they pose a threat to both mother and baby. This has impeded the growth of chemical-based pregnancy care products.

Stretchmark minimizers is the largest segment of the global pregnancy care products market owing to rising concern of stretchmarks during gestation period. Breast creams and toning/firming lotions are expected to experience lucrative demand over the forecast period owing to increasing awareness and rising focus regrading post pregnancy body. Asia Pacific emerged as the dominant regional market owing to highest number of pregnancies and rising cognizance regarding adoption of pregnancy care products.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/pregnancy-care-products-market

Further key findings from the report suggest:

  • Stretchmark minimizers emerged as the largest segment owing to their high demand during pregnancy and rising awareness regarding the product
  • Asia Pacific dominated the market in 2017. Higher number of births and rising awareness among expecting mothers have facilitated the dominance of this region
  • Latin America is projected to witness rapid growth during the forecast period owing to rapid adoption of organic variants of pregnancy care products and increased product availability owing to telemarketing and other social media platforms
  • Some of the key players are Mama Mio US Inc.; Noodle & Boo Novena Maternity; Expanscience Laboratories, Inc.; E.T. Browne Drug Co., Inc.; and Clarins Group.

Women’s Health Diagnostics Market Size Worth $30.8 Billion By 2025

The global women’s health diagnostics market size is expected to reach USD 30.8 billion by 2025, according to a new report by Grand View Research, Inc. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women’s health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/womens-health-diagnostics-market

Further key findings from the report suggest:

  • Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
  • Cancer accounted for the highest share in the market in 2017. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
  • Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
  • Geographically, North America was the leading revenue contributor to the women’s health diagnostics market in 2017. It is anticipated to maintain its dominance through 2025, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices
  • Some of the key players are Siemens Healthcare Private Limited; Hologic, Inc.;GE Healthcare; F. Hoffmann-La Roche Ltd.; bioMérieux SA; Koninklijke Philips N.V; Abbott; Becton, Dickinson and Company, Quest Diagnostics, Inc.; and PerkinElmer, Inc.

Migraine Drugs Market Size Worth $7.8 Billion By 2025

The global migraine drugs market size is expected to be valued at USD 7.8 billion by 2025, as per a new report by Grand View Research, Inc., exhibiting an 18.0% CAGR during the forecast period. The market is largely driven by factors such as a rise in disease prevalence, development of novel therapies, lifestyle changes, and hormonal medications.

Migraine is a debilitating neurological disease characterized by recurrent attacks of severe throbbing head pain that can last for more than three days. Migraine pain may get worse on movement, preventing the patient from carrying out normal, day-to-day activities. In about one-third of attacks, both sides of the head, face, or neck are affected.

Over the past five years, the global migraine drugs market has been relatively stagnant, with the market mainly dominated by usage of generic triptans and other off-label drugs. Majority of the currently prescribed drugs for both acute and preventative treatment are associated with poor efficacy and an unfavorable side-effect profile.

Launch of Amgen/ Novartis’ CGRP mAb Aimovig and Teva Pharma’s Ajovy is the first step toward revolutionizing the treatment paradigm of migraine prevention. For drug manufacturers likely to enter the market by 2019, such as Eli Lilly, Alder BioPharma, and Biohaven Pharma, pricing will be a key differentiating factor as all CGRP-based therapies have a similar efficacy and safety profile.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/migraine-drugs-market

Further key findings from the report suggest:

  • Germany leads the European market, driven by rising disease prevalence, novel drug launches, and an increase in R&D activities
  • The acute migraine treatment market will be supported by the rapid uptake of novel drug classes such as CGRP receptor antagonists and ditans currently under active investigation in multiple Phase II/III trials
  • Biohaven’s rimegepant is expected to face competition from Allergan’s ubrogepant, which has shown superior efficacy in Phase III trials compared to rimegepant
  • Eli Lilly’s Phase III 5-HT1F receptor agonist Lasmiditan is expected to be a novel first-line non triptan acute treatment option for patients in whom triptans are contradicted
  • Approximately 20% of patients seeking preventive treatment for migraine do not respond to available generic medications. Several biologics and small molecules drugs are undergoing active development to target high unmet needs in the preventive treatment segment
  • Drugs with novel targets in early-phase development include AOBiome Therapeutics’ AOB-203 (antibacterial), Winston Pharma’s Dolorac (histamine H1 receptor antagonists), NeuroAxons’ NXN-188 (a combination of NOS inhibitor and a triptan), and Biohaven’s BHV-3500 (gepant). These novel agents are under evaluation for both episodic and chronic migraine in multiple Phase I/II trials.

Veterinary Reference Laboratory Market Worth $5.13 Billion By 2025

The global veterinary reference laboratories (VRL) market is expected to reach USD 5.13 billion by 2025, according to a new report by Grand View Research, Inc. Increase in incidence of zoonotic diseases is a key driving factor for market growth. Increase in adoption of integrated diagnostic systems coupled with information ecosystems for veterinary diagnostics is anticipated to fuel development.

Rise in demand for advanced diagnostic tests and growing awareness amongst consumers are some of the factors expected to boost demand over the coming years. Moreover, companies are investing in R&D for the advancement of test kits for cost-effective diagnosis & monitoring of animal health, which is expected to boost growth. Some of the advancements in this market include efficient information management systems used in animal diagnostic applications, vaccine banks, and mobile apps for continuous monitoring. High focus toward innovation in veterinary health is anticipated to fuel the demand for reference labs. For instance, Innovative Medicines Initiative (IMI) is a public-private partnership that supports pharmaceutical innovations in Europe.

In addition, MediLab Secure, a laboratory network project was established, which aims to identify emerging viruses& pathogens in 19 countries in the Mediterranean regions and 57 labs were involved. Furthermore, increase in the number of government initiatives to promote veterinary diagnostics products is presumed to drive the overall growth. 

Click the link below:
http://www.grandviewresearch.com/industry-analysis/veterinary-reference-laboratory-vrl-market

Further Key Findings From the Study Suggest:

  • The clinical chemistry analyzers segment held the dominant share of the market as of 2016 owing to growing demand for veterinary diagnostics products
  • Increase in instances of contamination in pet foods that cause severe illnesses and deaths amongst animals is expected to boost the demand for toxicology testing services
  • Production animals accounted for largest revenue share in 2016 owing to their highest consumption rate
  • The market was dominated by North America and is expected to retain its position throughout the forecast period
  • Presence of prominent industry players, advanced healthcare infrastructure, and high healthcare expenditure are some of the factors responsible for growth
  • Companies offering reference laboratories are focusing on the development of cost-effective diagnostic solutions for animal health
  • IDEXX Laboratories, Inc. held a dominant share owing to its presence across the globe and a wide product portfolio of advanced diagnostic tests
  • Strategies such as regional expansion, new product developments, merger & acquisitions, and research collaborations are anticipated to propel growth
  • For instance, in January 2017, Mars, Inc. announced the agreement for acquiring VCA Inc. in a probe to capture higher share

Intraoperative Neuromonitoring Market Worth $3.6 Billion By 2025

The global Intraoperative Neuromonitoring market size is expected to reach USD 3.6 billion by 2025, based on a new report by Grand View Research, Inc. The market is anticipated to witness significant growth in the forecast period, which can be attributed to the hospitals adopting intraoperative monitoring in a wide spectrum of surgeries.

Major surgeries pose a risk to the nervous system that necessitates neuromonitoring. This has resulted in the growing popularity of intraoperative neuromonitoring (IONM) amongst surgical teams, surgeons, and hospitals. It results in reduced cases of revision surgeries, postoperative complications, and permanent impairment.

Industry players are acquiring smaller companies to expand their product offerings and geographical presence. For instance, in June 2016, Biotronic NeuroNetwork, LLC, headquartered in Michigan, was acquired by NuVasive, Inc., in a transaction worth USD 98 million.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/intraoperative-neuromonitoring-market

Further key findings from the study suggest:

  • Insourced IONM dominated the market in 2015, which is attributed to the rising number of surgeries and emphasis on patients during the procedures. IONM is utilized to minimize the neurological morbidity caused by operative manipulations. This offers detection of injuries during the operation and minimizes the risk of permanent nerve damage. Hospitals have adopted intraoperative monitoring and have trained technologists, who are supervised by neurologists and physiologists during the procedures.
  • Outsourced IONM is also gaining popularity and is expected to grow at a rapid rate over the forecast period Hospitals and healthcare centers choose to outsource their IONM needs due to benefits such as cost-efficiency and availability of focused service providers.
  • Geographically, North America dominated the industry in 2015 and is expected to maintain its position during the forecast period. It is accepted as a standard of care by the medical community in this region due to its benefits. New neurosurgeons and orthopedic surgeons are being trained to adopt this technique during procedures.
  • Asia Pacific is anticipated to observe the fastest growth over the coming years. The rising number of surgeries, developing economies, growing capacity of patients to bear expenses, and the presence of a large patient pool are few factors contributing to this growth.
  • Prominent players operating in the intraoperative neuromonitoring market include are Biotronic NeuroNetwork, LLC; Medtronic; Accurate Monitoring; NuVasive Inc.; Natus Medical Incorporated; SpecialtyCare; Sentient Medical Systems; and NeuroMonitoring Technologies, Inc.

UV Sanitizer Travel Wand Market Size Worth $209.9 Million By 2027

The global UV sanitizer travel wand market size is anticipated to reach USD 209.9 million by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 12.6% from 2020 to 2027. The increasing rate of infectious diseases in hospitals, low power consumption, and ease of portability for cleaning small objects in the home and commercial spaces are major factors driving the product demand. Increasing usage of the product in order to prevent cross-contamination and reduce pathogens, bacteria, and germs on objects is acting as a major driver for the market.

Companies in the market are focusing on gaining market share by increasing expenditure on advertising via social media and introducing new products in the market. For instance, in June 2020, Spark Innovation LLC launched a new UV travel wand with a light wavelength of 240-280nm and is certified by FCC, CE, and RoSH. Additionally, to save power and improve safety, the travel wand has a smart auto timing off in 180 seconds and an extra thoughtful Child lock to avoid kids’ misuse. This factor is acting as a major driver for the market.

The recent outbreak of coronavirus disease (Covid-19) is estimated to increase the adoption of UV sanitizer travel wand among consumers. In terms of application, the residential segment held the largest share in 2019 and is estimated to be the fastest-growing segment from 2020 to 2027. Rising awareness among consumers pertaining to a number of infectious bacteria present on the daily used objects is acting as a major driver for increasing the adoption of UV sanitizer travel wand. The commercial segment is estimated to witness growth in the coming years owing to rising demand from the healthcare sector. As per Shenzhen UVLED Optical Technology Co. Ltd., from January to February 2020, the company’s brand 59S has sold over 8000 units per day and 1000+ hospitals were using the company’s brand 59S UV travel wand owing to the recent outbreak of Covid-19 in China.

The offline distribution channel dominated the market with a revenue-based share of 69.3% in 2019. Brick and mortar is the most preferred distribution channel due to their provision of detailed instructions about usability by the product specialists. Many consumers in the market prefer purchasing from the stores to find the right fit as per their convenience and get the right product as per their needs.

North America dominated the market with a revenue-based share of 40.5% in 2019. Demand in the region is high as consumers in the region are more aware and willing to spend on innovative and value-added products. Mature and higher expenditure power of the healthcare sector in this region is resulting in increasing adoption of products to reduce the number of hospital infectious diseases.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/uv-sanitizer-travel-wand-market

Further key findings from the study suggest:

  • The residential application segment dominated the market with a share of 63.1% in 2019
  • The online distribution channel is expected to expand at the fastest CAGR of 13.6% from 2020 to 2027
  • Asia Pacific is expected to witness the fastest growth over the forecast period with a revenue-based CAGR of 13.9% from 2020 to 2027

Frozen Pizza Market Size Worth $25.2 Billion By 2027

The global frozen pizza market size is expected to reach USD 25.2 billion by 2027, expanding at a CAGR of 3.2%, according to a new report by Grand View Research, Inc. Rising demand for the ready-to-eat food coupled with the immense popularity of pizzas among millennials, the young generation, and the working-class population across the globe is the key factor for market growth. Moreover, changing lifestyles and food preferences owing to a busy work schedules are also offering new scope for the market.

Over the past few years, pizza has achieved massive popularity as an iconic dish among the young generation and working-class population across the world. Moreover, rising house party culture is offering new market opportunities across the globe. Frozen pizzas have evolved as a ready to prepare food item for small get together. It takes less than 20 minutes to be prepared and contains a healthy dose of veggies, carbohydrates, protein, calcium, fats, and vitamins. It is often enjoyed with salads and fizz drinks, which makes it perfect for small gatherings. These consumer trends are anticipated to drive the market over the forecast period.

North America dominated the market and accounted for a revenue share of more than 35.0% in 2019. The U.S. and Canada are the largest consumers of frozen food owing to their higher shelf life and popularity. The popularity of such products is so high in the U.S that the ‘National Pizza Day’ is celebrated every year on the 9th of February. Moreover, according to Alto-Hartley, Inc., a kitchen equipment and installation company in the U.S., more than 40.0% of the U.S. population eats pizza every week. These consumer trends are propelling the demand for the product in the regional market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/frozen-pizza-market

Further key findings from the study suggest:

  • Regular was the largest product segment with a market share of more than 40.0% in 2019 and expected to maintain dominance over the forecast
  • The medium product segment is expected to witness a CAGR of 3.5% from 2020 to 2027. Rising trend of house parties among college grads, the young generation, and the working-class population is opening new scope for the product in the global market
  • HoReCa (Hotel/Restaurant/Café) was the largest distribution channel segment with a market share of more than 59.1% in 2019 and anticipated to maintain the dominance over the forecast period owing to the increasing occurrence of QSR (Quick Restaurant Services) chains
  • In Asia Pacific, the market is anticipated to witness a CAGR of 4.0% from 2020 to 2027. With the increasing popularity of pizzas in developing countries like China, India, Bangladesh, and the Philippines, the region is expected to remain one of the key potential regions.

Smart Bed Market Size Worth $3.1 Billion By 2027

The global smart bed market size is anticipated to reach USD 3.1 billion by 2027, expanding at a CAGR of 4.5%, according to a new report by Grand View Research, Inc. Rising prominence for gaining a healthy sleep through the infusion of sensor-based advanced technology is the growing demand for smart beds. In addition, rising penetration of smart homes across regions is also paving way for technologically integrated household products, thereby paving the way for increased growth of the market.

The rapid development of smart home technology and their penetration across developed nations of America and Europe is positively impacting the demand for the product. According to the European Commission in 2017, Europe’s smart home revenue is expected to reach USD 19.0 billion by 2021, through its massive markets in the U.K. and Germany. Additionally, useful features compiled in the product such as customized mattress firmness that can sense and react to body temperature, tracking breathing, heart rates, and restfulness is gaining consumer’s attention.

Increasing instances of sleeping disorders among individuals particularly in the U.S. is deriving higher traction in the industry. According to American Sleep Association (ASA), insomnia is the most common sleep disorder, with short term issues reported by about 30.0% of adults and chronic insomnia by 10.0% in the country as of December 2019. In addition, 37.0% of those among 20-39-year-olds, and 40.0% of those among 40-59-year-olds expressed short sleep duration. While 35.3% of adults reported less than 7 hours of sleep during a typical day. These instances have raised the need for healthy and quality duration of sleep among consumers, thereby driving product demand in various application segments including households, hospitals, and hospitality.

In terms of application, the residential segment held a dominant position in the market in 2019. Lifestyle inflation among low, middle as well as high-income individuals are paving the way for increased spending among consumers towards relaxation and comfort, thereby scaling the demand for smart beds. Also, new innovations led by manufacturers in the industry with new product launches are likely to ramp up the sales for the product. For instance, in February 2019, Eight Sleep introduced a new biometric-monitoring smart bed.

The specialty stores segment accounted for a dominating revenue-based share of 66.5% in 2019. These stores provide training to their employees to assist customers and few of them also offer price-matching guarantees. In addition, major retail chains are focusing on establishing new stores with innovative layout, which is projected to support the growth of this segment in the coming years.

North America dominated the market with a revenue share of 60.2% in 2019. Increasing penetration of home automation in the region is also boosting the demand for smart furniture such as smart beds. According to the European Commission in 2017, smart home revenue in the U.S. is expected to grow over three-fold between 2016 and 2021, exceeding USD 32.0 billion. Additionally, various sleep-related disorders prevalent in the U.S. is triggering higher demand for quality sleep patterns among individuals. According to the American Sleep Association, 50-70 million adults in the U.S. have a sleep disorder. Also, around 25.0 million adults in the U.S. have obstructive sleep apnea.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/smart-bed-market

Further key findings from the study suggest:

  • The hospital application segment is expected to reach USD 628.4 million by 2027 and is anticipated to witness a CAGR of 5.2% from 2020 to 2027
  • The specialty stores segment was valued at USD 1.4 billion in 2019 and is expected to reach USD 2.1 billion by 2027
  • In Asia Pacific, the market is expected to witness substantial growth over the forecast period with a revenue-based CAGR of 5.6% from 2020 to 2027.

Enhanced Water Market Size Worth $11.3 Billion By 2027

The global enhanced water market size is expected to reach USD 11.3 billion by 2027, expanding at a CAGR of 8.3%, according to a new report by Grand View Research, Inc. These products are extremely popular among people suffering from kidney stones, bladder infection, fever, vomiting, and diarrhea. Enhanced water is also highly recommended for pregnant and breastfeeding women. Moreover, these products are consumed by people involved in a high-intensity workout and sports enthusiasts. Increasing the adoption of enhanced water among all age groups is expected to positively influence market growth. Health benefits associated with these products, along with the rising interest of millennials in sports and fitness-related activities, play a substantial role in boosting the demand for electrolyte hydration drinks. Moreover, increasing the number of product launches to suit the changing need of customers is driving market growth.

In June 2020, Daily Edge launched a new Enhanced Fruit Drinks, which is intended for providing support to increase hydration level and improve gut functions. It claims to provide a natural performance boost to its consumers. The product is available in flavors such as coconut citrus, berry punch, blood orange mango, and tropical ginger. The company claims that the product is 100% natural, free from caffeine and dairy, with no-GMO ingredients, and does not require to be refrigerated.

Consumers are focusing on purchasing hydration beverages owing to the associated health benefits such as digestion and circulation and for enhancing their appearance since adequate hydration leads to clearer and healthier skin. Such benefits are expected to drive the consumption of electrolyte hydration drinks among health-conscious consumers. The shifting interest of millennials towards sports and fitness activities is expected to further drive the market across the globe.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/enhanced-water-market

Further key findings from the report suggest:

  • Flavored products registered a sale of USD 3.6 billion in 2019. The product is preferred as it is a perfect replacement for all modern beverages that are not considered appropriate for health but yet are consumed because of their taste
  • The plain product category is expected to account for the largest revenue share during the forecast period with a CAGR of 8.6% from 2020 to 2027. These products are the perfect replacement for regular water and have the least possibility of having a certain color or flavor added to them.
  • The online distribution channel is expected to register the fastest CAGR of 8.9% during 2020 to 2027. The dominance of Generation Y, Z, and Alpha in the consumer segment who are more into shopping through the electronic media is driving the segment
  • In Asia Pacific, the market is expected to register a CAGR of 8.9% from 2020 to 2027. Rising spending on fitness among millennials in developing economies including China and India is expected to promote the scope of products such as hydration drinks among buyers.

Online Book Services Market Size Worth $27.8 Billion By 2027

The global online book services market size is anticipated to reach USD 27.8 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.8% from 2020 to 2027. The rising number of digitally-savvy readers, coupled with increasing usage of smartphones and tablets for reading books online, is likely to spur market growth.

The online books are gaining significant popularity over traditional books owing to easy accessibility online and convenience offered. As per the independent research, e-book penetration was 10.5% in 2018 and is expected to reach around 12% by 2022. Besides, a growing number of adults who own either a tablet, smartphone, or an e-reader device is expected to create a positive outlook for the market in the coming years.

Although e-book subscription services have existed for several years and currently, they are witnessing significant traction. Subscription services are known to give users access to huge, deep catalogs of content at a fixed monthly price. Very few players in the market have achieved a level of success in generating revenue through these models, for instance, as of 2020, Amazon has over 2.5 million and Scribd, Inc. has 1 million paying subscribers. However, other major players are channelizing on this model to gain a competitive edge in the market.

Several players operating in the market are focusing on strategic measures to reach a large number of consumers to boost revenue growth. For instance, in May 2020, Media Do Holdings announced that it is planning to enable blockchain e-books distribution. The company specializes in the distribution of digital products, like e-books, and upon seeing significant sales before and after the lockdown order, the company is looking to invest approximately USD 2.8 million for the blockchain e-books distribution project. The company added that the blockchain e-books distribution would be introduced first to My Anime List, which is considered the world’s biggest social community and database for anime and manga.

However, the low penetration of smartphones and similar devices in emerging countries can lead to low sales of online books, which is ultimately likely to impede market growth up to some extent over the forecast period.

By product type, the trade segment is projected to remain at the forefront in terms of share and growth rate over the forecast period. Many consumers are inclined towards reading fiction, non-fiction, and literature among others. Easy availability of such books online at minimum prices is foreseen to drive its demand in the coming years.

Asia Pacific is foreseen to expand at a maximum CAGR of 7.1% over the forecast period. Growing usage of smartphones and similar devices, rising internet penetration, and growing consumers’ preference for online books over printed ones are likely to fuel market growth in the coming years. In addition, closure of non-essential business amidst pandemics, such as physical bookstores and schools, as an effort to curtail the spread of the virus has surged the demand for online books. For instance, in April 2020, during the lockdown period, the Media Do Holdings recorded a 20% year-on-year growth on the sales of digital books.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/online-book-services-market

Further key findings from the study suggest:

  • The trade product segment is expected to reach USD 20.0 billion by 2027
  • Asia Pacific is expected to witness substantial growth over the forecast period with a revenue-based CAGR of 7.1% from 2020 to 2027.
  • The key market players are focusing on strategic initiatives such as blockchain distribution to reach a larger consumer base